INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION

INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION was reported 48 times

INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FLUOROESTRADIOL F 18 2 0.0909
1 LIDOCAINE HCL AND MENTHOL 1 0.0065
2 PIFLUFOLASTAT F-18 1 0.0030
3 HYDROQUINONE 1 0.0017
4 IOHEXOL 7 0.0008
5 ERDAFITINIB 1 0.0008
6 ACARBOSE 1 0.0003
7 ZANUBRUTINIB 1 0.0002
8 LISDEXAMFETAMINE DIMESYLATE CAPSULES 1 0.0002
9 INCLISIRAN 1 0.0001
10 REMDESIVIR 1 0.0001
11 METHYLPHENIDATE HYDROCHLORIDE 4 0.0001
12 POSACONAZOLE 1 0.0001
13 EXTENDED PHENYTOIN SODIUM 1 0.0001
14 ESTRADIOL TRANSDERMAL 2 0.0000
15 TIZANIDINE 1 0.0000
16 MESALAMINE 1 0.0000
17 BORTEZOMIB 3 0.0000
18 LISDEXAMFETAMINE DIMESYLATE 1 0.0000
19 PAROXETINE HYDROCHLORIDE 1 0.0000
20 DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE 1 0.0000
21 ESTRADIOL 2 0.0000
22 BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE 2 0.0000
23 FENTANYL 2 0.0000
24 LIDICAINE 1 0.0000
25 LIRAGLUTIDE 1 0.0000
26 LIDOCAINE, MENTHOL 1 0.0000
27 LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 1 0.0000
28 LIDOCAINE 4% 1 0.0000
29 HYDROCODONE BITARTRATE AND ACETAMINOPHEN 1 0.0000
30 MELOXICAM 1 0.0000
31 LIDOCAINE HYDROCHLORIDE 1 0.0000
32 ONABOTULINUMTOXINA 1 0.0000
33 VEDOLIZUMAB 1 0.0000
34 HYDROMORPHONE HYDROCHLORIDE 1 0.0000
35 BUPRENORPHINE 1 0.0000
36 POTASSIUM CHLORIDE ORAL 1 0.0000
37 POTASSIUM CHLORIDE 1 0.0000
38 GABAPENTIN 3 0.0000
39 ALPRAZOLAM 1 0.0000
40 RIVAROXABAN 1 0.0000
41 OXYCODONE HYDROCHLORIDE 1 0.0000
42 PANTOPRAZOLE 1 0.0000
43 METFORMIN ER 500 MG 1 0.0000
44 LENALIDOMIDE 1 0.0000